Clene (CLNNW) had the highest return on January 23, 2024 by a US stock, returning 124.4%.

ASSET	DATE	% RETURN
Clene (CLNNW)	1/23/2024	124.44%
Rail Vision Ltd Ordinary Share (RVSN)	1/23/2024	114.52%
Nuvve (NVVE)	1/23/2024	91.67%
Osisko Development Corp Warrant expiring 5/27/2027 (ODVWZ)	1/23/2024	81.82%
Rail Vision Ltd Warrant (RVSNW)	1/23/2024	80%
error (ZVZZT)	1/23/2024	69.34%
Sunshine Biopharma Inc Warrant (SBFMW)	1/23/2024	52.36%
JIN MEDICAL INTERNATIONAL LTD Ordinary Shares (ZJYL)	1/23/2024	51.73%
Carbon Revolution Public Limited Company Warrant (CREVW)	1/23/2024	51.45%
Nuvve (NVVEW)	1/23/2024	50.5%
Big Tree Cloud Holdings Limited Warrants (DSYWW)	1/23/2024	40%
Palladyne AI (PDYNW)	1/23/2024	36%
Sonder (SONDW)	1/23/2024	35.88%
Lexaria Bioscience (LEXXW)	1/23/2024	35.19%
GameSquare (GAME)	1/23/2024	33.86%
LMF Acquisition Opportunities (ICUCW)	1/23/2024	32.02%
Triller (ILLRW)	1/23/2024	30.16%
Talkspace (TALKW)	1/23/2024	28%
SenesTech (SNES)	1/23/2024	27.79%
Psyence Biomedical Ltd Warrant (PBMWW)	1/23/2024	26.67%
Gaxosai (GXAI)	1/23/2024	26.32%
Nixxy (NIXXW)	1/23/2024	25.93%
GeneDx (WGSWW)	1/23/2024	25%
Scilex (SCLXW)	1/23/2024	23.75%
Estrella Immunopharma (ESLA)	1/23/2024	22.73%